| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?
|
Carbone, Antonino
|
|
|
132 |
1 |
p. 17-22
|
artikel
|
| 2 |
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
|
Bachy, Emmanuel
|
|
|
132 |
1 |
p. 49-58
|
artikel
|
| 3 |
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
|
LaCasce, Ann S.
|
|
|
132 |
1 |
p. 40-48
|
artikel
|
| 4 |
CEP: a new β2 integrin ligand in inflamed tissue
|
Sperandio, Markus
|
|
|
132 |
1 |
p. 4-5
|
artikel
|
| 5 |
Concurrent JAK2 mutation and isolated del(5q) associated with marrow fibrosis and small hypo/monolobated megakaryocytes
|
Tremblay-LeMay, Rosemarie
|
|
|
132 |
1 |
p. 112
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
132 |
1 |
p. ii
|
artikel
|
| 7 |
Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
|
Chinn, Ivan K.
|
|
|
132 |
1 |
p. 89-100
|
artikel
|
| 8 |
Getting to transplant in Hodgkin lymphoma: BVB
|
Gordon, Leo I.
|
|
|
132 |
1 |
p. 1-3
|
artikel
|
| 9 |
HLH: genomics illuminates pathophysiological diversity
|
Tesi, Bianca
|
|
|
132 |
1 |
p. 5-7
|
artikel
|
| 10 |
How and when I do allogeneic transplant in CLL
|
Gribben, John G.
|
|
|
132 |
1 |
p. 31-39
|
artikel
|
| 11 |
Novel therapeutics for hemophilia and other bleeding disorders
|
Callaghan, Michael U.
|
|
|
132 |
1 |
p. 23-30
|
artikel
|
| 12 |
Oxidative modifications of extracellular matrix promote the second wave of inflammation via β2 integrins
|
Yakubenko, Valentin P.
|
|
|
132 |
1 |
p. 78-88
|
artikel
|
| 13 |
Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease
|
Sandhu, Kam
|
|
|
132 |
1 |
p. 101-110
|
artikel
|
| 14 |
Phenotyping rare hepcidin deficiency
|
Bardou-Jacquet, Edouard
|
|
|
132 |
1 |
p. 7-8
|
artikel
|
| 15 |
Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil
|
Herbaux, Charles
|
|
|
132 |
1 |
p. 9-16
|
artikel
|
| 16 |
T-cell prolymphocytic leukemia negative for surface CD3 and CD45
|
Thakral, Beenu
|
|
|
132 |
1 |
p. 111
|
artikel
|
| 17 |
The FLIPI nowadays: validation and modification
|
Hoster, Eva
|
|
|
132 |
1 |
p. 3-4
|
artikel
|
| 18 |
The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
|
Rasche, Leo
|
|
|
132 |
1 |
p. 59-66
|
artikel
|
| 19 |
Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors
|
Maifrede, Silvia
|
|
|
132 |
1 |
p. 67-77
|
artikel
|
Tijdschrift beschrijving